Identifying the chemical switches that turn different parts of our immune system on and off is opening up new avenues for treating diseases such as Parkinson’s, Alzheimer’s, cancer and rheumatoid arthritis – and potential new uses for discarded drugs, according to Professor Luke O’Neill, an immunologist at Trinity College Dublin, Ireland. Professor O'Neill's research has been part-funded by European Research Council funding.
Read more here
2 days ago - 2019 Competitive Start Fund (CSF)
4 days ago - Reform of Trade Mark Law